Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis

Richard A. Plasse; Stephen W. Olson; Christina M. Yuan; Robert Nee

doi:10.1093/CKJ/SFZ134

Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis

Richard A. Plasse, Stephen W. Olson, Christina M. Yuan, Robert Nee^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Biotin (vitamin B7) is a dietary supplement that can lead to falsely abnormal endocrine function tests. The impact of biotin on both 25-hydroxyvitamin D [25(OH)D] and intact parathyroid hormone (iPTH) have not been previously described in end-stage renal disease (ESRD). A woman with ESRD on hemodialysis taking biotin 10 mg daily had a 25(OH)D spike from 25 to >100 ng/mL and an iPTH decrease from 966 to 63 pg/mL. After discontinuation of biotin, her 25(OH)D and iPTH returned to baseline. Biotin can cause erroneous 25(OH)D and iPTH results in ESRD that could adversely affect patient care.

Original language	English
Pages (from-to)	710-712
Number of pages	3
Journal	Clinical Kidney Journal
Volume	13
Issue number	4
DOIs	https://doi.org/10.1093/CKJ/SFZ134
State	Published - 2020
Externally published	Yes

Keywords

25-hydroxyvitamin D
Biotin
Dialysis
End-stage renal disease
Parathyroid hormone

Access to Document

10.1093/CKJ/SFZ134

Cite this

@article{41952e697fde41beb0e77fcee1663211,

title = "Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis",

abstract = "Biotin (vitamin B7) is a dietary supplement that can lead to falsely abnormal endocrine function tests. The impact of biotin on both 25-hydroxyvitamin D [25(OH)D] and intact parathyroid hormone (iPTH) have not been previously described in end-stage renal disease (ESRD). A woman with ESRD on hemodialysis taking biotin 10 mg daily had a 25(OH)D spike from 25 to >100 ng/mL and an iPTH decrease from 966 to 63 pg/mL. After discontinuation of biotin, her 25(OH)D and iPTH returned to baseline. Biotin can cause erroneous 25(OH)D and iPTH results in ESRD that could adversely affect patient care.",

keywords = "25-hydroxyvitamin D, Biotin, Dialysis, End-stage renal disease, Parathyroid hormone",

author = "Plasse, {Richard A.} and Olson, {Stephen W.} and Yuan, {Christina M.} and Robert Nee",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",

year = "2020",

doi = "10.1093/CKJ/SFZ134",

language = "English",

volume = "13",

pages = "710--712",

journal = "Clinical Kidney Journal",

issn = "2048-8505",

number = "4",

}

TY - JOUR

T1 - Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis

AU - Plasse, Richard A.

AU - Olson, Stephen W.

AU - Yuan, Christina M.

AU - Nee, Robert

N1 - Publisher Copyright: © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2020

Y1 - 2020

N2 - Biotin (vitamin B7) is a dietary supplement that can lead to falsely abnormal endocrine function tests. The impact of biotin on both 25-hydroxyvitamin D [25(OH)D] and intact parathyroid hormone (iPTH) have not been previously described in end-stage renal disease (ESRD). A woman with ESRD on hemodialysis taking biotin 10 mg daily had a 25(OH)D spike from 25 to >100 ng/mL and an iPTH decrease from 966 to 63 pg/mL. After discontinuation of biotin, her 25(OH)D and iPTH returned to baseline. Biotin can cause erroneous 25(OH)D and iPTH results in ESRD that could adversely affect patient care.

AB - Biotin (vitamin B7) is a dietary supplement that can lead to falsely abnormal endocrine function tests. The impact of biotin on both 25-hydroxyvitamin D [25(OH)D] and intact parathyroid hormone (iPTH) have not been previously described in end-stage renal disease (ESRD). A woman with ESRD on hemodialysis taking biotin 10 mg daily had a 25(OH)D spike from 25 to >100 ng/mL and an iPTH decrease from 966 to 63 pg/mL. After discontinuation of biotin, her 25(OH)D and iPTH returned to baseline. Biotin can cause erroneous 25(OH)D and iPTH results in ESRD that could adversely affect patient care.

KW - 25-hydroxyvitamin D

KW - Biotin

KW - Dialysis

KW - End-stage renal disease

KW - Parathyroid hormone

UR - http://www.scopus.com/inward/record.url?scp=85101099281&partnerID=8YFLogxK

U2 - 10.1093/CKJ/SFZ134

DO - 10.1093/CKJ/SFZ134

M3 - Article

AN - SCOPUS:85101099281

SN - 2048-8505

VL - 13

SP - 710

EP - 712

JO - Clinical Kidney Journal

JF - Clinical Kidney Journal

IS - 4

ER -

Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis

Abstract

Keywords

Access to Document

Fingerprint

Cite this